neuroregeneration
Polylaminin: A Biomimetic ECM Scaffold for Neural Repair
Introduction
The adult central nervous system (CNS) has a limited capacity for self-repair. Followi...
Chondroitinase ABC (ChABC): Enzymatic Degradation of Inhibitory ECM After Spinal Cord Injury
Introduction
After spinal cord injury (SCI), the central nervous system responds with inflammatio...
Axonis Therapeutics: Advancing KCC2 Modulation for Neural Recovery
Introduction
Axonis Therapeutics is a biotechnology company developing first-in-class oral small-...
New Approaches to Modulating CSPG Signaling After Spinal Cord Injury
A recent wave of studies is taking a closer look at how chondroitin sulfate proteoglycans (CSPGs) co...
NVG-291: Exploring Its Potential in Spinal Cord Injury and Neuroprotection
Introduction
NVG-291 is a promising experimental agent designed to address neuroinflammation, a key...